Cognition Therapeutics Inc

CGTX NASDAQ Santé & Biotech États-Unis US19243B1026
1.25 $
4.17 %

Cognition Therapeutics est centrée sur la découverte et le développement de médicaments pour le traitement des troubles neurodégénératifs, tels que la maladie d'Alzheimer.

Price history of Cognition Therapeutics Inc
Price history of Cognition Therapeutics Inc

Performance & Momentum

6 Months 26.09 %
1 Year 377.91 %
3 Years 41.95 %
5 Years 90.68 %

Similar stocks to Cognition Therapeutics Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone